AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
9min chapter
Bristol’s $14 Billion Karuna Deal Highlights Race for New Drugs
Bloomberg Businessweek
Bristol Myers Squibb's $14 Billion Acquisition of Karuna Therapeutics
This chapter discusses the news of Bristol Myers Squibb acquiring Karuna Therapeutics for $14 billion, highlighting the race among drug makers to expand their portfolio. It explores the implications of the deal, the competitive process involved, and potential areas of interest for drug makers. The chapter also discusses the prospects of M&A activity in the biotech sector and the broader market going forward.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode